Search clinical trials for: Locoregional treatment

Total 63219 results

Sun Yat-sen University

Recruiting

Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLM

Colorectal Neoplasms Malignant

China
National Cancer Institute, Egypt

Recruiting

Metastases Directed Therapy for Oligometastatic Breast Cancer

Breast Cancer | Metastatic Cancer | Metastatic Breast Cancer

Egypt
Ruijin Hospital

Recruiting

Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology (SAHARA-04)

Breast Cancer

France
Samsung Medical Center

Recruiting

Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast Cancer (SALT-LRR)

Breast Cancer

Korea, Republic of
National Cancer Institute (NCI)

Recruiting

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer

Gastric Adenocarcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Gastroesophageal Junction Adenocarcinoma | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage II Gastric Cancer AJCC v8 | Clinical Stage IVA Gastric... and other conditions

United States
Sun Yat-sen University

Not yet recruiting

Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma

Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma

China
Oana Danciu
Novartis Pharmaceuticals

Recruiting

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR)

HER2-negative Breast Cancer | Locoregional Recurrence | Hormone Receptor-positive Breast Cancer

United States
Wake Forest University Health Sciences

Recruiting

Randomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures

Pain, Postoperative | Rib Fracture Multiple

United States
Fundacao Champalimaud
European Commission; Cankado GmbH; Bocconi University; INESC TEC - Institute for... and other collaborators

Recruiting

Comparing Decision on Aesthetics After Breast Cancer Locoregional Treatment. (CINDERELLA)

Breast Cancer

Germany, Israel, Italy, Portugal, Poland
UNICANCER
National Cancer Institute, France; GORTEC

Recruiting

Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers (PembroMetaRT)

Squamous Cell Carcinoma of Head and Neck

France
Assistance Publique - Hôpitaux de Paris
Laboratoires Vivacy; INTERmedic; Laboratoires IPRAD PHARMA

Recruiting

Evaluation of Innovative Therapeutic Approaches of Vaginal and Sexual Dysfunction After Breast Cancer Treatment (EPIONE-01)

Breast Cancer

France
Dr. Paul Buderath

Recruiting

European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III (PMMR)

Endometrial Cancer

Germany
University of Texas Southwestern Medical Center

Recruiting

Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC (Lipiodol TACE)

Hepatocellular Carcinoma

United States
Ontario Clinical Oncology Group (OCOG)

Recruiting

Hypofractionated LocoRegional Radiotherapy in Breast Cancer (RHEAL)

Breast Neoplasms | Lymphedema | Radiotherapy

Canada
Shanghai Zhongshan Hospital
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.

Hepatic Carcinoma

China
Institut Bergonié
Ministry of Health, France

Recruiting

Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and Over (SARCOLD)

Soft Tissue Sarcoma Adult

France
National Cancer Institute (NCI)
NRG Oncology; Canadian Cancer Trials Group

Active, not recruiting

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Head and Neck Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Lip and Oral Cavity Cancer AJCC v8 | Stage... and other conditions

United States, Canada
Hoffmann-La Roche

Completed

A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy

Carcinoma, Hepatocellular

Spain
HistoSonics, Inc.

Active, not recruiting

The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER US)

Liver Neoplasms | Hepatocellular Carcinoma | Liver Metastases

United States
Sun Yat-sen University

Active, not recruiting

PD-1 Antibody Versus Best Supportive Care After Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma (DIPPER)

Nasopharyngeal Neoplasms

China
Clinical Hospital Center Rijeka

Completed

SLNB After Neoadjuvant Treatment in Node Positive Patients

Sentinel Lymph Node Biopsy | Progression, Disease | Locoregional Neoplasm Recurrence
UNICANCER
Pfizer

Active, not recruiting

Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients (PALATINE)

Surgery | Breast Cancer Stage IV | Radiotherapy

France
Pfizer

Completed

A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)

Breast Neoplasms

United States, Canada, Spain, United Kingdom, Australia, Belgium, Korea, Republic of, Japan, Czechia, France, Germany, Hungary, Ireland, Italy, Poland, Russian Federation, Taiwan, Ukraine
M.D. Anderson Cancer Center

Withdrawn

Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer

Recurrent Head and Neck Squamous Cell Carcinoma | Unresectable Head and Neck Squamous Cell Carcinoma
Pfizer

Active, not recruiting

A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]

Breast Neoplasms

China, Taiwan, Hong Kong, Singapore, Thailand
Mayo Clinic

Terminated

Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer

Head and Neck Cancer

United States
Radboud University Medical Center

Completed

Incidence, Risk Factor, Treatment and Overall Survival of Locoregionally Recurrent Colon Cancer

Colonic Neoplasms | Neoplasm Recurrence, Local
Regina Elena Cancer Institute
Valeria Landoni; Diana Giannarelli; Giuseppe Sanguineti; Silvia Takanen; Serena Nucciarelli and other collaborators

Completed

Ten Fraction Adjuvant Hypofractionated Radiotherapy in Node Positive Breast Cancer (HIPOMAMMLINF)

Breast Cancer

Italy
Karolinska Institutet

Withdrawn

Individualized Locoregional Treatment of Initially Biopsy-proven Node-positive Breast Cancer After Primary Systemic Therapy (INDAX)

Breast Cancer
Tata Memorial Hospital

Completed

Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation

Cancer of the Breast

India
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Trial of Image-Guided Adaptive Conformal Photon vs Proton Therapy, With Concurrent Chemotherapy, for Locally Advanced Non-Small Cell Lung Carcinoma: Treatment Related Pneumonitis and Locoregional Recurrence

Non-Small-Cell Lung Carcinoma

United States
Chaosu Hu

Unknown

De-escalation Protocols in Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
University Hospital, Bordeaux

Completed

Efficacy of Oral Prednisolone on Pain Reduction in Emergency Care of Acute Irreversible Pulpitis (PULPISOLONE)

Pulpitis

France
Yonsei University

Completed

The Efficacy of Involved-field Radiation Therapy for Residual or Locoregionally Recurrent Epithelial Ovarian Cancer After Definitive Treatment; Multi-institutional Clinical Trial

Ovarian Cancer (Epithelial)

Korea, Republic of
Imunon

Completed

Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall (DIGNITY)

Breast Cancer

United States
Angiodynamics, Inc.

Completed

NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer

Pancreatic Adenocarcinoma

Italy
National Cancer Institute, Naples
Federico II University; University of Campania "Luigi Vanvitelli"

Terminated

Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors (LOTUS)

Neuroendocrine Tumors

Italy
Sun Yat-sen University

Unknown

Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy

Lymphoma, | Non-Hodgkin Lymphoma, | Extranodal NK/T-cell Lymphoma,Nasal-type,

China
Emory University

Completed

Analysis of Percutaneous Ablations for Cancer Treatment

Cancer

United States
Isarna Therapeutics GmbH

Completed

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Glioblastoma | Anaplastic Astrocytoma

Germany, Austria, Georgia, India, Israel, Russian Federation
Spanish Cooperative Group for the Treatment of...
Sanofi; Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma

Esophageal Carcinoma

Spain
Institute of Oncology Ljubljana

Unknown

Treatment Selection According to Skin Reaction to Cetuximab

Head and Neck Cancer

Slovenia
Fondazione IRCCS Istituto Nazionale dei Tumori,...
Gastro Intestinal Surgery and Liver Transplantation; The Hepato-Oncology Group...

Completed

Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma | Liver Cancer

Italy
National Taiwan University Hospital

Unknown

Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy

Hepatocellular Carcinoma

Taiwan
Federico II University
Ospedali dei Colli

Completed

GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma (SS-HCC)

Advanced Hepatocellular Carcinoma

Italy
Nantes University Hospital

Completed

Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones

Immunotherapy

France
MOSS S.p.A.

Not yet recruiting

NovoX®Cup as Primary Dressing After Breast Reduction

Mammaplasty | Wound Healing Disorder | Post-Surgical Complication

Austria
King's College Hospital NHS Trust
Chiesi Limited

Not yet recruiting

Less Invasive Surfactant Administration in Late Preterm or Early Term Born Infants

Respiratory Distress Syndrome | Surfactant Deficiency Syndrome Neonatal | Preterm Pregnancy
NeuFit - Neurological Fitness and Education

Recruiting

Impact of Direct Current Electrical Stimulation on Treatment of Lumbosacral Radiculopathy

Radiculopathy Lumbar | Radiculopathy Sacral | Radiculopathy Multiple Sites

United States

Search clinical trials for: Locoregional treatment

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations